Skip to content
stockhead logo
close
  • JUST IN
  • SECTIONS
    • Mining
    • Health & Biotech
    • Technology
    • Energy
    • Food & Agriculture
  • FEATURES
    • IPO Watch
    • Escrow Watch
    • Director Trades
    • Private-i
    • Aftermarket
    • The Secret Broker
  • PRIMERS
  • STOCKHEAD TV
  • SEARCH
  • SUBSCRIBE

Health & Biotech

The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs

February 19, 2019February 19, 2019 | Rachel Williamson

Health & Biotech

Weed week: In Canada pot is hot; in Australia it’s just a steady glow

February 7, 2019February 7, 2019 | Rachel Williamson

Capital says 'no' to drugs' ... ends its cannabis ambitions. Pic: Gettty

Health & Biotech

If pot is so hot, why aren’t cannabis directors buying their own companies?

February 6, 2019February 6, 2019 | Rachel Williamson

Health & Biotech

Profitable pot stock Elixinol is getting excited about US growth opportunities

January 31, 2019January 31, 2019 | Sam Jacobs

Health & Biotech

Nearly every country in the world is better at pot than Australia: Elixinol boss

January 24, 2019January 23, 2019 | Daniel Paproth

News

Lunchtime ASX small cap wrap: who deserves an award today?

January 23, 2019 | Daniel Paproth

Health & Biotech

Another Aussie pot stock has just crossed the Tasman thanks to new NZ weed laws

January 23, 2019 | Daniel Paproth

Health & Biotech

Weed week: America says no to munchies

January 10, 2019January 11, 2019 | Rachel Williamson

IPO Watch

IPOs of 2018: The few that floated when most didn’t

December 21, 2018February 9, 2019 | Rachel Williamson

Picture: Getty

Health & Biotech

US Congress has two weeks left to vote on legalising hemp farming

December 11, 2018December 11, 2018 | Rachel Williamson

George W. Bush looking confused at the US Chamber of Commerce in 2004. Pic: Getty

Health & Biotech

Weed week: wtf happened with MMJ?

November 22, 2018February 9, 2019 | Rachel Williamson

Health & Biotech

Weed week: here’s all the news driving the cannabis market (including hemp gin)

November 8, 2018November 8, 2018 | Rachel Williamson

« Previous 1 2 3 4 5 Next » Next »

Hear it first with our daily newsletter.

We don't spam. Learn more about our Privacy Policy

Morning UpdateLunch Update

We don't spam. Read our privacy policy

Hear it first with our daily newsletter.

We don't spam. Learn more about our Privacy Policy

Morning UpdateLunch Update

We don't spam. Read our privacy policy

Most Popular

  • 1
    Gold: Drilling at Newcrest’s mammoth Haverion discovery is getting super close to Artemis’ project boundary
  • 2
    Bio-Gene CEO: Key breakthrough in mozzie-killing tech gives the company a ‘golden ticket’ to commercialisation
  • 3
    Don’t put it all on black: the money managers’ warning for 2020
  • 4
    D.I.V.O.R.C.E. ASX style not Dolly style
  • 5
    Is this explorer closing-in on a new Victorian gold discovery? This analyst certainly believes so…

Editor's Picks

  • 1
    Year in review — Here’s how Stake members approached US markets in 2019
  • 2
    Spies and corporate takeovers: what’s next for the China-Australia story?
  • 3
    IPO Watch: Aerometrex closes 84pc higher on ASX entry; is 6th best debut in 2019
  • 4
    Explorers Podcast: The sweets of mining in Sweden, high-grade VMS and Guyanese gold
  • 5
    ‘No other market offers more growth prospects’ for med-techs than India; but they’ll have to go low-cost
stockhead logo
ABOUT US MEET THE TEAM CONTACT US ADVERTISE
facebook icon twitter icon instagram icon linkedin icon email icon

Stockhead is providing factual information where there is a reasonable likelihood of doubt.
The information is not intended to imply any recommendation or opinion about a financial product.

Terms of use Privacy Policy Copyright 2019
Do NOT follow this link or you will be banned from the site!

Hear it first with our daily newsletter.

We don't spam. Learn more about our Privacy Policy

Morning UpdateLunch Update

We don't spam. Read our privacy policy